NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-257-2009-1-NZ-06 Use Of IL-15 To Increase Thymic Output and to Treat Lymphopenia NZ National Stage 597814 Abandoned
NIMH E-245-2006-1-US-01 SCHIZOPHRENIA-RELATED ISOFORM OF KCNH2 AND DEVELOPMENT OF ANTIPSYCHOTIC DRUGS US CIP 13/357,416 8871443 Abandoned PDF
NICHD E-068-2012-0-US-01 Device for Simulating Explosive Blast And Imaging Biological Specimen US 61/590,209 Abandoned
NCI E-053-2012-0-US-01 Peptide And Peptide Mimetic Binding Antagonists Of Polo-like Kinase 1 Polo Box Domain and Methods of Use US 61/588,470 Abandoned
NCI E-014-2007-0-NZ-21 SMOOTHENED POLYPEPTIDES AND METHODS OF USE NZ DIV 597715 Abandoned
NIAID E-203-2010-0-AU-06 Methods for Amplification and Detection of Prions AU National Stage 2012207454 Abandoned
NIAID E-203-2010-0-PCT-02 Methods for Amplification and Detection of Prions PCT PCT PCT/US2012/021561 Expired
NIAID E-203-2010-0-EP-03 Methods for Amplification and Detection of Prions EP National Stage 12701626.9 Abandoned
NIAID E-203-2010-0-CN-08 Methods for Amplification and Detection of Prions CN National Stage 201280013852.3 Abandoned
NIAID E-203-2010-0-CA-05 Methods for Amplification and Detection of Prions CA National Stage 2824863 Abandoned
NIEHS E-012-2011-0-PCT-02 Modulation of Lrch4 Activity and Therapeutic Application Thereof PCT PCT PCT/US12/021538 Expired
NIAID E-203-2010-0-JP-07 Methods for Amplification and Detection of Prions JP National Stage 2013-550540 Abandoned
NIAID E-293-2008-0-US-05 Human Monoclonal Antibodies Against Influenza A H5 Hemagglutinin For Prevention And Treatment Of H5N1 Infection US DIV 13/351,066 Abandoned
NCATS E-074-2012-0-US-01 Organic Compounds US 61/587,030 Abandoned
NIAID E-319-2004-2-US-15 Optimized Vaccines To Provide Protection Against Ebola And Other Viruses US DIV 13/349,917 9012618 Expired PDF
NCI E-184-2009-0-US-09 Combination Immunotherapy Compositions And Methods US National Stage 13/264,846 10383924 Issued PDF
NIAID E-074-2011-2-BE-08 INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS BE EP 12734409.1 Issued
NIAID E-074-2011-2-CH-09 INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS CH EP 12734409.1 Issued
NIAID E-074-2011-2-GB-12 INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS GB EP 12734409.1 Issued
NIAID E-074-2011-2-DE-10 INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS DE EP 12734409.1 Issued
NIAID E-074-2011-2-FR-11 INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS FR EP 12734409.1 Issued
NIAID E-074-2011-2-EP-04 INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS EP National Stage 12734409.1 Issued
NIAID E-074-2011-2-CN-02 INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS CN National Stage 201280004927.1 Issued
NIAID E-074-2011-2-JP-05 INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS JP National Stage 2013-548625 Issued
NCATS E-083-2012-0-PCT-02 INHIBITORS OF EYA2 PCT PCT PCT/US2012/020805 Expired
NIAID E-074-2011-2-PCT-01 INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS PCT PCT COMB PCT/US2012/020830 Expired
NIAID E-074-2011-2-EG-03 INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS EG National Stage 1086/2013 Pending
NCATS E-087-2012-0-US-01 CLK and DYRK Inhibitors and Methods of Use Thereof US 61/584,935 Abandoned
NCI E-021-2001-0-US-13 Chromosome 3p21.3 Genes Are Tumor Suppressors US DIV 13/346,528 Abandoned
NCI E-042-2012-0-US-01 METHODS OF TREATING OR PREVENTING INSULIN RESISTANCE AND ASSOCIATED DISEASES AND CONDITIONS US 61/584,526 Abandoned
NIAAA E-060-2010-0-HK-10 Hydroxybutyrate Ester And Medical Use Thereof HK National Stage 12100075.4 Issued
NHLBI E-080-2002-0-US-05 Modified Defensins And Their Use US DIV 13/344,509 8609607 Abandoned PDF
NHLBI E-274-2010-0-PCT-02 Single Channel MRI Guidewire PCT PCT PCT/US2012/020139 Expired
NHLBI E-274-2010-0-EP-03 Single Channel MRI Guidewire EP National Stage 12732508.2 Abandoned
NCI E-018-2005-2-US-09 Methods Of Diagnosing And Treating Cancer Using B-Catenin Splice Variants US DIV 13/342,877 1000-08-13 Issued PDF
NIBIB E-238-2010-0-PCT-02 One Step Fluorine-18 Labeling of Biological Substrates and Uses of Fluorine-18 Labeled Biological Substrates PCT PCT PCT/US2012/020098 Expired
NEI E-099-2010-0-EP-05 METHODS OF TREATING AGE-RELATED MACULAR DEGENERATION EP National Stage 12732397.0 Abandoned
NCI E-057-1997-0-US-46 PSEUDOMONAS EXOTOXIN A-Like Chimeric Immunogens US DIV 13/342,741 Abandoned
NEI E-099-2010-0-AU-03 METHODS OF TREATING AGE-RELATED MACULAR DEGENERATION AU National Stage 2012204574 Abandoned
NEI E-099-2010-0-PCT-02 METHODS OF TREATING AGE-RELATED MACULAR DEGENERATION PCT PCT PCT/US12/020050 Expired
NCI E-001-2012-0-US-01 NATIVE AND AGONIST CTL EPITOPES OF THE MUC1 TUMOR ANTIGEN US 61/582,723 Abandoned
NIA E-165-2011-0-US-01 Human Soluble Receptor For Advanced Glycation End Products (sRAGE), Methods of Preparing Human sRAGE, And Treatment Methods Using sRAGE US 61/582,574 Abandoned
NEI E-099-2010-0-CA-04 METHODS OF TREATING AGE-RELATED MACULAR DEGENERATION CA National Stage 2823549 Abandoned
NCI E-290-2006-2-CH-32 MIR-21 for diagnosing poor survival prognosis colon adenocarcinoma. CH EP 11196265.0 Abandoned
NCI E-290-2006-2-ES-31 MIR-21 for diagnosing poor survival prognosis colon adenocarcinoma. ES EP 11196265.0 Abandoned
NCI E-290-2006-2-FR-33 MIR-21 for diagnosing poor survival prognosis colon adenocarcinoma. FR EP 11196265.0 Abandoned
NCI E-290-2006-2-DE-83 MIR-10a for diagnosing poor survival prognosis colon adenocarcinoma. DE EP 11196264.3 Abandoned
NCI E-290-2006-2-FR-84 MIR-10a for diagnosing poor survival prognosis colon adenocarcinoma. FR EP 11196264.3 Abandoned
NCI E-290-2006-2-GB-85 MIR-10a for diagnosing poor survival prognosis colon adenocarcinoma. GB EP 11196264.3 Abandoned
NCI E-290-2006-2-EP-24 MIR-10a for diagnosing poor survival prognosis colon adenocarcinoma. EP DIV 11196264.3 Abandoned